How We Treat HER2-Positive Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How We Treat HER2-Positive Metastatic Breast Cancer

Published:2021-08 Issue:04 Volume:42 Page:370-375
ISSN:0971-5851
Container-title:Indian Journal of Medical and Paediatric Oncology
language:en
Short-container-title:Indian J Med Paediatr Oncol

Author:

Komaranchath Ashok S.¹,Mathew Aju²³

Affiliation:

1. Department of Oncology, Aster Medcity, Kochi, Kerala, India

2. Department of Oncology, MOSC Medical College, Kolenchery, Kerala, India

3. Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0041-1731861.pdf

Reference32 articles.

1. American Society of Clinical Oncology; College of American Pathologists. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;A C Wolff;J Clin Oncol,2013

2. Therapy landscape in patients with metastatic HER2-positive breast cancer: data from the PRAEGNANT real-world breast cancer registry;M P Lux;Cancers (Basel),2018

3. CLEOPATRA Study Group. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer;S M Swain;N Engl J Med,2015

4. “Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome;P Vici;Oncotarget,2016

5. “Triple positive” breast cancer - a novel category?;G Iancu;Rom J Morphol Embryol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP